Adial Pharmaceuticals Inc (ADIL)
$2.27
$-0.10
(-4.03%)
As on 03-Jun-2026 12:39EDT
Market cap
$5 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-4.3
-
Face value
--
-
Shares outstanding
2,143,621
9 Years Aggregate
CFO
$-47.65 Mln
EBITDA
$-64.80 Mln
Net Profit
$-73.36 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Adial Pharmaceuticals (ADIL)
| -58.8 | 46.1 | -8.3 | -87.0 | -76.5 | -73.2 | -- |
|
BSE Sensex
| -12.2 | -3.3 | -7.3 | -8.6 | 5.9 | 7.5 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Adial Pharmaceuticals (ADIL)
| -78.2 | -45.4 | -65.4 | -91.9 | 58.8 | -29.5 | -52.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Adial Pharmaceuticals (ADIL)
|
2.3 | 5.1 | 0.0 | -7.8 | -- | -189 | -- | 1.5 |
| 73.0 | 10,974.2 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 18.1 | |
| 216.6 | 13,845.5 | 867.5 | 506.6 | -2.8 | -- | 25.5 | 25.6 | |
| 71.6 | 10,421.8 | 105.8 | -829.6 | -715.0 | -- | -- | 60.3 | |
| 50.8 | 12,688.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 16.7 | 6.5 | |
| 128.5 | 17,196.9 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 300.7 | 9,110.1 | 417.3 | 225.0 | 42.8 | 18.6 | 41.4 | 7.1 | |
| 473.3 | 11,464.9 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 22.4 | |
| 443.6 | 12,769.3 | 2,678.3 | 460.4 | 21.1 | 103.2 | 28.2 | 20.4 | |
| 270.3 | 9,756.7 | 0.0 | -326.5 | -- | -37.2 | -- | 7.0 |
Shareholding Pattern
View DetailsAbout Adial Pharmaceuticals (ADIL)
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist,... which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia. Read more
-
CEO, President & Director
Mr. Cary John Claiborne MBA
-
CEO, President & Director
Mr. Cary John Claiborne MBA
-
Headquarters
Glen Allen, VA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Adial Pharmaceuticals (ADIL)
What is the current share price of Adial Pharmaceuticals Inc (ADIL) Today?
The share price of Adial Pharmaceuticals Inc (ADIL) is $2.27 (NASDAQ) as of 03-Jun-2026 12:39 EDT. Adial Pharmaceuticals Inc (ADIL) has given a return of -76.46% in the last 3 years.
What is the current PB & PE ratio of Adial Pharmaceuticals Inc (ADIL)?
Since, TTM earnings of Adial Pharmaceuticals Inc (ADIL) is negative, P/E ratio is not available.
The P/B ratio of Adial Pharmaceuticals Inc (ADIL) is 1.48 times as on 29-May-2026, a 67 discount to its peers’ median range of 4.44 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.03
|
0.04
|
|
2024
|
-0.38
|
1.24
|
|
2023
|
-0.27
|
0.46
|
|
2022
|
-0.02
|
0.07
|
|
2021
|
-0.14
|
0.77
|
What is the 52 Week High and Low of Adial Pharmaceuticals Inc (ADIL)?
The 52-week high and low of Adial Pharmaceuticals Inc (ADIL) are Rs 18.90 and Rs 1.31 as of 03-Jun-2026.
What is the market cap of Adial Pharmaceuticals Inc (ADIL)?
Adial Pharmaceuticals Inc (ADIL) has a market capitalisation of $ 5 Mln as on 29-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Adial Pharmaceuticals Inc (ADIL)?
Before investing in Adial Pharmaceuticals Inc (ADIL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.